Get started
Work

Supplementary Figure S2 from Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S2 describes the effects of MEK inhibition on cell proliferation and BCL-2 family protein levels.
DOI: 10.1158/1535-7163.22505634
Authors: Claudia Iavarone, Ioannis K. Zervantonakis, Laura M. Selfors, Sangeetha Palakurthi, Joyce F. Liu, Ronny Drapkin, Ursula A. Matulonis, Dorothy Hallberg, Victor E. Velculescu, Joel D. Leverson, Deepak Sampath, Gordon B. Mills, Joan S. Brugge
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362609996
Cites:
Cited by:
Related to: 10